Pfizer

Pfizer shares are trading a little under 1% higher pre-market on Monday. However, they remain well off the 2020 highs following the decline seen over recent weeks. After the initial rally seen across the start of December as traders…

Shares in pharmaceutical company of the moment, Pfizer, are trading higher pre-market on Wednesday as demand continues to grow in response to vaccination headlines. The first doses of the vaccine have been administered in the UK this week…

Shares in Pfizer are trading around 4% higher pre-market on Wednesday following news that the UK government has approved the vaccine developed by itself and German partner firm BioNTech. The UK government is now the first in the world to…

As illustrated in a Nature article published on Tuesday, scientists are puzzled by the preliminary results of covid tests. Given expectations and historic vaccination results, there appears to be something odd going on. And something…

Shares in US pharmaceutical company Pfizer have seen plenty of action over the last week. The company announced last week that itself and its German partner BioNTech had successfully proven their candidate COVID vaccine to be over 90%…

Another Drop for the Buck The US Index lost further momentum on Wednesday as it ended the session 0.10% down. More ground was given up as the greenback now trades precariously towards the 92 region. Sentiment shifted on positive …

Gold Gold has been firmly lower this week as the markets continued to digest the latest news within the COVID landscape. Pfizer and its German partner BioNTech announced that their vaccine has achieved more than 90% effectiveness in…

Shares in US pharmaceutical firm Pfizer are trading almost 1% higher pre-market on Wednesday. Pfizer and its German partner BioNTech have been working on a COVID vaccine. They have recently announced that they could be the first to…

Shares in US pharmaceutical company Pfizer are trading around 0.5% lower pre-market on Tuesday, extending the losses seen across recent days. Indeed, the sell-off comes despite news this week that Pfizer’s joint clinical trials with German…